Meridian Bioscience (FRA:MR4) EV-to-FCF : 20.02 (As of May. 05, 2024)

Meridian Bioscience EV-to-FCF Chart

Meridian Bioscience Annual Data
	Trend	Sep13	Sep14	Sep15	Sep16	Sep17	Sep18	Sep19	Sep20	Sep21	Sep22
EV-to-FCF		Get a 7-Day Free Trial					20.34	12.93	16.86	17.52	18.02

Meridian Bioscience Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EV-to-FCF	Get a 7-Day Free Trial															17.52	14.66	13.29	14.56	18.02

Competitive Comparison of Meridian Bioscience's EV-to-FCF

For the Diagnostics & Research subindustry, Meridian Bioscience's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Meridian Bioscience's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Meridian Bioscience's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Meridian Bioscience's EV-to-FCF falls into.

Meridian Bioscience EV-to-FCF Calculation

Meridian Bioscience's EV-to-FCF for today is calculated as:

Meridian Bioscience's current Enterprise Value is €1,331.3 Mil.
Meridian Bioscience's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €66.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meridian Bioscience  (FRA:MR4) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Meridian Bioscience's PE Ratio for today is calculated as:

Meridian Bioscience's share price for today is €30.90.
Meridian Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.870.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Meridian Bioscience EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Meridian Bioscience (FRA:MR4) Business Description